From 2013 to 2023, the sold production of pharmaceutical preparations in Finland demonstrated generally consistent growth, starting from 1.34 billion Euros and reaching 1.81 billion Euros in 2023. Despite fluctuations, including a notable dip in 2020 and 2021, the overall compound annual growth rate (CAGR) over the last decade reflects a positive trajectory. The 2023 value indicates a recovery from the previous years' slight declines, with a year-on-year increase of 2.37%.
The forecasts from 2024 to 2028 suggest a continued growth with the 5-year CAGR projected at 1.69%. This indicates steady progress, with an expected value crossing 2 billion Euros by 2028. The last two years before 2023 showed marginal increases, signaling a period of stabilization post-recession.
Future trends to watch for:
- Technological advancements in pharmaceutical production.
- Policy changes impacting the pharmaceutical industry.
- Global market integration and competition.
- Impacts of global health crises on production demand.
